| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |